Beth C Seidenberg has bought stock on 9 days since Oct 2019

Beth C. Seidenberg, M.D. is a Director at Kyverna Therapeutics, Inc. (KYTX), a position she has held since September 2018.( She is a founding Managing Director at Westlake Village BioPartners (since 2018) and previously served as a Managing Member of Kleiner Perkins life sciences funds, where she incubated and invested in over 40 biotech companies.(

Dr. Seidenberg has a distinguished career in biotechnology, with senior R&D executive roles at Amgen (SVP, Head of Global Development & Chief Medical Officer), Bristol Myers Squibb, and Merck, where she developed treatments for diseases including AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological, and renal disorders, introducing 10 innovative products to market over 20 years.( She also serves on the boards of Sagimet Biosciences (since 2007, Chair of Compensation Committee), Vera Therapeutics, Acelyrin, and others.( Dr. Seidenberg earned a B.S. in biology and anthropology from Barnard College and an M.D. from the University of Miami, with residency training at Johns Hopkins University and George Washington University, and a fellowship at the NIH.(

Written by Perplexity from public sources.